FDA Inspection 771666 — Hospira, Inc.

Hospira, Inc. — FEI 1048698

The FDA completed an inspection of Hospira, Inc. on March 9, 2012 in Clayton, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 9, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures